PP (%) | BPG (%) | DOXY (%) | AMOX+P (%) | |
---|---|---|---|---|
No. of patients started treatment | 102 (52) | 26 (13) | 38 (19) | 4 (2) |
No. of patients completed treatment | 94 (92) | 26 (100) | 34 (89) | 4 (100) |
Serological Response | 86 (91) | 17 (65) | 27 (79) | 3 (75) |
Serological Failure | 3 (3) | 1 (4) | 3 (8) | 1 (25) |
Lost to Follow up <13 months | 5 (5) | 8 (31) | 4 (11) | 0 |
No. of patients did not complete treatment | 8 (8) | 0 | 4 (11) | 0 |
Serological Response | 7 (88) | 3 (75) | ||
Serological Failure | 1 (12) | 1 (25) | ||
Switched Treatment Regimen | 4 (4) | 0 | 1 (3) | 0 |
BPG | 1 (25) | 0 | 1 (100) | 0 |
Doxycycline | 3 (75) | 0 | 0 | 0 |
Serological Response | 4 (100) | 0 | 1 (100) | 0 |
Age | ||||
Median | 42 | 44 | 38 | 54 |
Range | 25–46 | 29–68 | 27–58 | 40–63 |
Syphilis Infection | ||||
Primary | 24 (24) | 9 (35) | 7 (18) | 1 (25) |
Secondary | 47 (46) | 12 (46) | 25 (66) | 1 (25) |
Early Latent | 31 (30) | 5 (19) | 6 (6) | 2 (50) |
CD4 at Diagnosis | ||||
Median | 576 | 654 | 534 | 728 |
Range | 126–1223 | 170–2384 | 274–847 | 404–1146 |
On ART at Diagnosis | ||||
Yes | 82 (80) | 21 (81) | 30 (80) | 4 (100) |
No | 20 (20) | 5 (19) | 8 (20) | 0 |
PP=procaine penicillin plus oral probenecid; BPG= benzathine penicillin G; DOXY= doxycycline; AMOX+P= amoxicillin plus oral probenecid; HART=HIV antiretroviral therapy